News & Events

BD (Becton, Dickinson and Company) today announced the completion of a major expansion of its corporate technology and innovation center in Research Triangle Park, North Carolina.The two-year, $12.7 million capital investment project will accommodate continuing growth at the Company’s BD Technologies facility, which currently supports 220 BD associates.

“For more than thirty years, BD Technologies has provided the scientific skills, talent and synergies essential to maintaining BD’s edge in innovation,” said Edward J. Ludwig, Chairman, President and Chief Executive Officer.“These most recent investments make it clear that our growing team in RTP will continue to drive the development of new life science and medical technologies at BD for years to come.”                     

The expansion features a new wing serving the Company’s Enterprise Network Operations Center, a world-class facility that provides financial, human resources, and other enterprise functions for BD’s global operations on a 24/7/365 basis.In addition, renovations are complete for more than 32,000sf devoted to BD researchers. Combined, the two projects created 14 new labs in addition to numerous offices, conference rooms and training facilities.

“BD Technologies provides an environment where new science is turned into technological innovations that will enable BD to advance its purpose of Helping All People Live Healthy Lives well into the future,” said Dr. Charles Goldstein, Vice President, Research.“It’s exciting to begin this new chapter of innovation in a region with a quality of life that consistently attracts the highest caliber of scientific talent.”

BD Technologies is known for such innovations as the development of BD’s proprietary Strand Displacement Amplification (SDA) technology that allows for specific infectious diseases to be quickly identified with greater sensitivity and specificity.Additionally, current research on Advanced Drug Delivery systems includes a federal partnership to develop more effective methods of administering biodefense vaccines for anthrax and other pathogens.Other functions present at the BD Technologies facility in the Triangle include a Computer-Aided Engineering and Rapid Prototyping Group, the Worldwide Medical Toxicology Group, a Microprocessor Group, and a new Clinical Development Group.

BD and North Carolina: Perfect Together

In 1897, two North Carolinians — Maxwell W. Becton and Fairleigh S. Dickinson — met by chance in Texarkana, Texas.The two medical equipment salesmen went together to New York, where the company now known as BD was founded.BD returned to North Carolina in the late 1960s, becoming one of the first large companies to build a research facility in Research Triangle Park in 1972.

BD’s second facility in North Carolina, located in Durham’s Treyburn Corporate Park, opened in 1991 and currently employs 300 associates.It produces pipets, cell inserts, tissue culture plates, dishes and roller bottles for BD Biosciences’ Discovery Labware unit.

BD Technologies established a private life sciences incubator, BD BioVenture Center, in 1999, giving 14 start-up companies access to state-of-the-art laboratories, equipment and business services and leading to the creation of 330 high-quality biotechnology jobs.All participating companies have remained in the local area and have raised over $500 million in venture capital funding, corporate partnerships and grants.

About BD